Eli Lilly 2009 Annual Report Download - page 106

Karen N. Horn, Ph.D. Age 66 Director since 1987
Retired President, Private Client Services, and Managing Director, Marsh, Inc.
Ms. Horn serves as the board’s lead director. She served as president of private client services
and managing director of Marsh, Inc. from 1999 until her retirement in 2003. Prior to joining
Marsh, she was senior managing director and head of international private banking at Bankers
Trust Company; chairman and chief executive officer of Bank One, Cleveland, N.A.; president of
the Federal Reserve Bank of Cleveland; treasurer of Bell Telephone Company of Pennsylvania;
and vice president of First National Bank of Boston. Ms. Horn serves as director of T. Rowe
Price Mutual Funds; Simon Property Group, Inc.; and Norfolk Southern Corporation and vice
chairman of the U.S.-Russia Investment Foundation. She previously served on the board of
Fannie Mae and Georgia-Pacific Corporation. Ms. Horn has been senior managing director of
Brock Capital Group since 2004.
Board Committees: compensation (chair) and directors and corporate governance
John C. Lechleiter, Ph.D. Age 56 Director since 2005
Chairman, President, and Chief Executive Officer
Dr. Lechleiter is chairman, president, and chief executive officer of Eli Lilly and Company. He
served as president and chief operating officer from 2005 to 2008. He joined Lilly in 1979 as a
senior organic chemist and has held management positions in England and the U.S. He was
named vice president of pharmaceutical product development in 1993 and vice president of
regulatory affairs in 1994. In 1996, he was named vice president for development and regulatory
affairs. Dr. Lechleiter became senior vice president of pharmaceutical products in 1998 and
executive vice president for pharmaceutical products and corporate development in 2001. He
was named executive vice president for pharmaceutical operations in 2004. He is a member of
the American Chemical Society, Business Roundtable, and Business Council. Dr. Lechleiter
serves on the boards of Pharmaceutical Research and Manufacturers of America (PhRMA);
Xavier University (Cincinnati, Ohio); Fairbanks Institute (Indianapolis); Indianapolis Downtown,
Inc.; the Central Indiana Corporate Partnership; and the United Way of Central Indiana. He also
serves on the board of Nike, Inc. and previously served on the board of Great Lakes Chemical
Corporation.
Board Committees: none
Class of 2012
The following four directors will continue in office until 2012.
Martin S. Feldstein, Ph.D. Age 70 Director since 2002
George F. Baker Professor of Economics, Harvard University
Dr. Feldstein is the George F. Baker Professor of Economics at Harvard University and president
emeritus of the National Bureau of Economic Research. From 1982 through 1984, he served as
chairman of the Council of Economic Advisers and President Ronald Reagan’s chief economic
adviser. Dr. Feldstein served as president and chief executive officer of the National Bureau of
Economic Research from 1977 to 1982 and 1984 to 2008. In 2009, President Obama appointed
him to the President’s Economic Recovery Advisory Board. He is a member of the American
Philosophical Society, a corresponding fellow of the British Academy, a fellow of the
Econometric Society, and a fellow of the National Association for Business Economics.
Dr. Feldstein is a trustee of the Council on Foreign Relations and a member of the Trilateral
Commission, the Group of 30, the American Academy of Arts and Sciences, and the Council of
Academic Advisors of the American Enterprise Institute and past president of the American
Economic Association. He previously served on the boards of American International Group, Inc.
and HCA Inc.
Board Committees: audit, finance, and public policy and compliance (chair)
8
PROXY STATEMENT